Stephen A. Hill, Director at Cellectar Biosciences, Inc. (CLRB), bought 9,390 shares at $2.12 ($20K) on 2016-04-20, disclosed to the SEC on 2016-04-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| LPCN | SELL | 2018-01-02 | $4K | — | Filing → |
| CBIO | BUY | 2015-12-18 | $10K | — | Filing → |
| LPCN | BUY | 2014-11-13 | $20K | — | Filing → |